Navigation Links
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Date:8/22/2007

Program will build on other successful GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] patient programs pioneered by Baxter

DEERFIELD, Ill., Aug. 22 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) today announced that it will launch GARDian, an innovative program that helps provide continued access for patients relying on GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (IGIV). IGIV products like GAMMAGARD LIQUID and GAMMAGARD S/D are immunoglobulin (IgG) replacement therapies containing broad-spectrum immunoglobulins and are indicated for patients with primary immunodeficiency. Primary immunodeficiency is a group of genetic disorders in which the immune system fails to produce adequate amounts of antibodies, thereby predisposing individuals to increased risk of infection.

IGIV users and physicians can experience changes involving their providers or site of care that can sometimes impede access to their preferred IGIV therapy. Baxter's GARDian program, which is expected to start early next year, will provide patients and physicians with continued access to GAMMAGARD LIQUID and GAMMAGARD S/D even when such changes occur.

GARDian is viewed as a logical extension of other successful patient- centric programs pioneered by Baxter. The hallmark of each of these programs is continued access to GAMMAGARD LIQUID and GAMMAGARD S/D. They include:

-- GAMMAssist -- An innovative program that allows eligible users of

GAMMAGARD to continue to receive their immunoglobulin therapy in the

event of a lapse in insurance.

-- Low IgA/Brand Intolerance Program -- A program providing patient access

to GAMMAGARD S/D selected
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. Weather information companies launch data product
7. TeraMedica launches information manager
8. GE Healthcare launches hybrid electronic record
9. Cedara launches new version of DICOM toolkit
10. Merge launches Spanish version of imaging tool
11. Orbitec will use $25 million Air Force contract to make small launch vehicle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014 The Alliance ... a survey of European physicians at the "1 ... and Biological Therapies" at the Spanish Ministry of ... by EuropaBio and the Spanish Bioindustry Association (ASEBIO), ... physicians from Spanish oncology and rheumatology societies, representatives ...
(Date:11/26/2014)... Whitehouse Laboratories is pleased to announce ... (New Jersey) Chamber of Commerce as a member. ... in the North Jersey area, offers Whitehouse Laboratories ... clients in the pharmaceutical and biotechnology areas that ... enables Whitehouse Laboratories a higher level of visibility ...
(Date:11/26/2014)... (PRWEB) November 25, 2014 The Pittcon ... its official conference and exposition mobile app, ... free download in the App Store for iOS and ... valuable resource tool before, during and after the event. ... details on exhibiting companies, technical sessions, Conferee Networking sessions ...
(Date:11/26/2014)... PLAINSBORO, N.J. and WILMINGTON, DE (PRWEB) November 26, 2014 ... the 2nd Annual MPN Heroes recognition reception on December ... Society of Hematology’s annual meeting. The MPN Heroes event ... significant contributions in the field of myeloproliferative neoplasms (MPNs). ... TV show "Nashville," will discuss his family's cancer journey ...
Breaking Biology Technology:ASBM Presents European Physicians Survey at Spanish Ministry of Health 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3Pittcon Releases 2015 Mobile App 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4
... September 2 According to a new,market research ... MarketsandMarkets ( http://www.marketsandmarkets.com ), the global,biosimilars market is ... recording,a CAGR of 89.1% from 2009 to 2014. ... to reduce the costs of blockbuster,biopharmaceuticals has created ...
... , WALTHAM, Mass., Sept. 2 Repligen Corporation ... and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at ... 9th, 2009 at 2:25 p.m. EDT at the New York Palace ... webcast of the presentation will be available via Repligen,s website at ...
... of the problem: In a swarm of small fish it ... found in the microcosm of atoms and molecules, whose behavior ... control over single electrons in a bunch, ultrashort light pulses ... Max Planck Institute of Quantum Optics (MPQ) in Garching and ...
Cached Biology Technology:MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 2MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 3Repligen to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Wednesday, September 9th, 2:25 p.m. EDT 2Repligen to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Wednesday, September 9th, 2:25 p.m. EDT 3Laser pulses control single electrons in complex molecules 2Laser pulses control single electrons in complex molecules 3
(Date:11/4/2014)... at the right time might actually help boost a ... help in understanding animal populations, pest control and managing ... the journal Trends in Ecology and Evolution , ... the kind of positive population effect an overall species ... on the size and developmental stage of the creatures ...
(Date:11/4/2014)... about the way our bodies are assembled during early ... they are supposed to become a nerve or a ... correct place and alignment? Researchers at the University of ... a new study, UM researchers describe the signaling systems ... at the head-trunk region. Their discovery may have important ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... NEW YORK , Aug. 15, 2013   ... authentication solutions, announced today the appointment of Michael ...  Fiorito,s appointment reinforces the adoption and expansion of ... enterprise market. In this role, Fiorito ...
... German researchers have identified four biomarkers that correctly determine ... accurate prediction of patient outcomes. Their results are published ... Molecular Diagnostics . Current prognosticators of bladder cancer, ... foci, have limited usefulness for clinicians since they do ...
... who often recall their dreams respond more strongly to their ... mysteries of human cognition. It is still not fully known ... them. A major difficulty for studying dreams is that they ... Ruby and colleagues from the Lyon Neuroscience Research Center chose ...
Cached Biology News:EyeLock Appoints Michael Fiorito Vice President of Enterprise Accounts 2MicroRNAs have diagnostic and prognostic potential in urinary bladder cancer 2Frontiers news briefs: Aug. 13 2Frontiers news briefs: Aug. 13 3